Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Behind the Study: Cholera Toxin and Age-associated Obesity

Oncotarget

December 27, 2021
Dr. Susan Erdman from Massachusetts Institute of Technology (MIT) discusses the 2019 research paper she co-authored, entitled, "Consuming cholera toxin counteracts age-associated obesity." continue reading »

New Study: Biomarkers Linked to the Progression of Endometrial Cancer

Oncotarget

December 22, 2021
Researchers identified differentially regulated signaling pathways and genes related to endometrial cancer (EC) disease progression. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue 26

Oncotarget

December 21, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget: Volume 12, Issue 26. continue reading »

Could Metformin and Rapamycin Replace Maintenance Chemotherapy?

Oncotarget

December 16, 2021
Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic adenocarcinoma. continue reading »

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

Oncotarget

December 13, 2021
Dr. Katherine Bever discusses research she co-authored that was published by Oncotarget, entitled, "An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma." continue reading »